[go: up one dir, main page]

UA50807C2 - Німесулідна гелева система для місцевого застосування і спосіб її отримання (варіанти) - Google Patents

Німесулідна гелева система для місцевого застосування і спосіб її отримання (варіанти)

Info

Publication number
UA50807C2
UA50807C2 UA99084652A UA99084652A UA50807C2 UA 50807 C2 UA50807 C2 UA 50807C2 UA 99084652 A UA99084652 A UA 99084652A UA 99084652 A UA99084652 A UA 99084652A UA 50807 C2 UA50807 C2 UA 50807C2
Authority
UA
Ukraine
Prior art keywords
local administration
gel formulation
topical gel
nimesulide
nimesulide topical
Prior art date
Application number
UA99084652A
Other languages
English (en)
Russian (ru)
Inventor
Стефано БАДЕР
Енріке Ейсерманн
Тіціана Монті
Original Assignee
Гелсінн Гелскер С.А.
Гелсинн Гелскер С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гелсінн Гелскер С.А., Гелсинн Гелскер С.А. filed Critical Гелсінн Гелскер С.А.
Publication of UA50807C2 publication Critical patent/UA50807C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

Цей винахід стосується німесулідної композиції для місцевого застосування, яка включає карбоксивініловий полімер, нейтралізований як речовина, що утворює гель, або поліакрил-ізопарафін і розчинник, вибраний з групи, яка містить етанол, ізопропанол і моноетиловий етер діетиленгліколю, а також способів їх приготування. Перевагами згаданої композиції є висока стабільність системи та біоспроможність активної речовини.
UA99084652A 1997-02-25 1998-02-20 Німесулідна гелева система для місцевого застосування і спосіб її отримання (варіанти) UA50807C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI000408A IT1289973B1 (it) 1997-02-25 1997-02-25 Sistemi gelificati di nimesulide per uso topico
PCT/EP1998/000990 WO1998037879A1 (en) 1997-02-25 1998-02-20 Nimesulide gel systems for topical use

Publications (1)

Publication Number Publication Date
UA50807C2 true UA50807C2 (uk) 2002-11-15

Family

ID=11376173

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99084652A UA50807C2 (uk) 1997-02-25 1998-02-20 Німесулідна гелева система для місцевого застосування і спосіб її отримання (варіанти)

Country Status (32)

Country Link
US (2) US20020119997A1 (uk)
EP (1) EP0971708B1 (uk)
JP (1) JP2001513093A (uk)
KR (1) KR100413143B1 (uk)
CN (1) CN1148174C (uk)
AT (1) ATE210437T1 (uk)
AU (1) AU723843B2 (uk)
BG (1) BG64664B1 (uk)
BR (1) BR9807729A (uk)
CA (1) CA2279277A1 (uk)
CU (1) CU22836A3 (uk)
CZ (1) CZ293665B6 (uk)
DE (2) DE971708T1 (uk)
DK (1) DK0971708T3 (uk)
EE (1) EE04041B1 (uk)
ES (1) ES2169506T3 (uk)
GE (1) GEP20022628B (uk)
HU (1) HU226122B1 (uk)
ID (1) ID22668A (uk)
IL (1) IL131128A (uk)
IS (1) IS2090B (uk)
IT (1) IT1289973B1 (uk)
MX (1) MXPA99007468A (uk)
NO (1) NO994040L (uk)
PL (1) PL190603B1 (uk)
PT (1) PT971708E (uk)
RS (1) RS49700B (uk)
RU (1) RU2181285C2 (uk)
SK (1) SK284809B6 (uk)
TR (1) TR199902034T2 (uk)
UA (1) UA50807C2 (uk)
WO (1) WO1998037879A1 (uk)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718356B2 (en) * 1998-01-12 2000-04-13 Panacea Biotec Limited A parenteral water-miscible non-intensely coloured injectable composition of non-steroidal anit-inflammatory drugs
GB2340751B (en) * 1998-08-12 2003-11-05 Edko Trading Representation Pharmaceutical compositions
RU2238086C2 (ru) * 1999-05-31 2004-10-20 Динеш Шантилал Пател Новая лекарственная форма n-(4-нитро-2-феноксифенил) метансульфонамида, способ ее получения и применения
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
EP1307232B1 (en) 2000-08-03 2007-03-07 Antares Pharma IPL AG Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
ES2222817B1 (es) * 2003-07-25 2007-03-01 Luis Ucelay Sanz Gel frio.
BRPI0414551B8 (pt) 2003-10-10 2021-05-25 Antares Pharma Ipl Ag formulação farmacêutica transdérmica ou transmucosa e método de protelação ou inibição da cristalização de um agente ativo
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
CA2646667C (en) 2006-04-21 2014-03-11 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
TR200906775A1 (tr) * 2009-09-02 2011-03-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Nimesulid ve kas gevşetici kombinasyonları
CN102068404A (zh) * 2009-11-25 2011-05-25 中国人民武装警察部队医学院 一种尼美舒利温度敏感水凝胶及其制备方法
UA121985C2 (uk) * 2015-01-23 2020-08-25 Др. Редді'З Лабораторіз Лімітед Нефарбуюча гелева композиція для місцевого застосування, яка містить німесулід
RU2593777C1 (ru) * 2015-04-20 2016-08-10 Общество с ограниченной ответственностью "Трейдсервис" Гелевая форма нимесулида, обладающая противовоспалительным и анальгетическим действием
CN108158993A (zh) * 2018-01-12 2018-06-15 连云港本草美汇医药科技有限公司 一种祛痘控油微乳凝胶剂及其制备方法与应用
US12440529B2 (en) 2020-09-22 2025-10-14 Alphyn Biologics, Inc. Topical Croton lechleri compositions and their use in the treatment of a bacterial colonization or primary or secondary bacterial infection of an underlying skin disorder
CA3209718A1 (en) * 2021-02-25 2022-09-01 Gary Michael PEKOE Composition for treatment of topical dermatological bacterial skin conditions
PL244577B1 (pl) 2021-12-16 2024-02-12 Univ Gdanski Sole nimesulidu i sposób otrzymywania kryształów soli nimesulidu
PL444224A1 (pl) 2023-03-28 2024-09-30 Uniwersytet Gdański Sól potasowa nimesulidu oraz sposób otrzymywania kryształów soli potasowych nimesulidu

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1251838B (it) * 1991-09-20 1995-05-26 Lpb Ist Farm Uso della nimesulide nel trattamento della cataratta
BE1008307A3 (fr) * 1994-06-16 1996-04-02 Europharmaceuticals Sa Sel de nimesulide hydrosoluble, solution aqueuse le contenant, sa preparation et son utilisation.
US5837735A (en) * 1994-10-05 1998-11-17 Helsinn Healthcare S.A. Antiinflammatory agent for external use
HUP9601442A3 (en) * 1995-07-25 1999-03-29 Panacea Biotec Ltd Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
PL183588B1 (pl) * 1995-10-05 2002-06-28 Helsinn Healthcare Sa Środek przeciwzapalny do użytku zewnętrznego zawierający nimesulid
HUP9601443A3 (en) * 1996-05-29 1999-03-29 Panacea Biotec Ltd Injectable analgetic pharmaceutical compositions for intramuscular use containing nimesulid, and process for producing them
IT1291278B1 (it) * 1996-07-05 1999-01-07 Errekappa Euroterapici S P A Preparazione farmaceutica a base di nimesulide per uso topico

Also Published As

Publication number Publication date
EE9900355A (et) 2000-02-15
YU38599A (sh) 2002-06-19
DE69802913D1 (de) 2002-01-24
DE69802913T2 (de) 2002-07-04
IS2090B (is) 2006-03-15
AU6499298A (en) 1998-09-18
DK0971708T3 (da) 2002-03-25
EP0971708A1 (en) 2000-01-19
IL131128A0 (en) 2001-01-28
CZ293665B6 (cs) 2004-06-16
IS5143A (is) 1999-07-30
US20030036563A1 (en) 2003-02-20
CN1148174C (zh) 2004-05-05
PT971708E (pt) 2002-05-31
RS49700B (sr) 2007-12-31
NO994040D0 (no) 1999-08-20
ID22668A (id) 1999-12-02
WO1998037879A1 (en) 1998-09-03
US20020119997A1 (en) 2002-08-29
IL131128A (en) 2003-11-23
SK284809B6 (sk) 2005-11-03
BR9807729A (pt) 2000-02-15
BG64664B1 (bg) 2005-11-30
KR20000075561A (ko) 2000-12-15
BG103645A (en) 2000-04-28
TR199902034T2 (xx) 1999-11-22
NO994040L (no) 1999-10-20
EE04041B1 (et) 2003-06-16
ATE210437T1 (de) 2001-12-15
US7186755B2 (en) 2007-03-06
PL190603B1 (pl) 2005-12-30
MXPA99007468A (es) 2004-05-05
RU2181285C2 (ru) 2002-04-20
CZ298699A3 (cs) 2000-02-16
IT1289973B1 (it) 1998-10-19
ITMI970408A1 (it) 1998-08-25
SK114199A3 (en) 2000-11-07
HUP0001486A3 (en) 2002-11-28
JP2001513093A (ja) 2001-08-28
KR100413143B1 (ko) 2003-12-31
HU226122B1 (en) 2008-04-28
EP0971708B1 (en) 2001-12-12
DE971708T1 (de) 2000-08-17
CA2279277A1 (en) 1998-09-03
CN1248165A (zh) 2000-03-22
GEP20022628B (en) 2002-02-25
AU723843B2 (en) 2000-09-07
ES2169506T3 (es) 2002-07-01
PL335141A1 (en) 2000-04-10
HUP0001486A2 (hu) 2000-10-28
HK1025265A1 (en) 2000-11-10
CU22836A3 (es) 2003-01-29

Similar Documents

Publication Publication Date Title
UA50807C2 (uk) Німесулідна гелева система для місцевого застосування і спосіб її отримання (варіанти)
WO1999051271A3 (en) Compositions comprising glycol derivatives and alcohols
ES2175413T5 (es) Formulaciones de aerosol
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
SI0991407T2 (en) Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations
NO961136L (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
WO2001005355A3 (en) Formulations for il-11
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
MY101536A (en) Anti-inflammatory and analgesic tape for external use
ATE251443T1 (de) Antimikrobielle kosmetische präparate
CA2352915A1 (en) Pharmaceutical compositions containing mupirocin
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
ES2040774T3 (es) Procedimiento para la preparacion de una formulacion medicamentosa.
EP0056681A3 (en) Levonantradol and n-methyllevonantradol formulations
WO2002041875A3 (de) Verfahren zur herstellung leicht löslicher arzneimittelformulierungen und entsprechende formulierungen
CA2202520A1 (en) Lyophilized pharmaceutical preparations capable of providing aqueous drug composition having property of reversible thermosetting gelation
IT1273460B (it) Formulazioni farmaceutiche ad azione antivirale per uso topico
AU6015398A (en) Method for removing high boiling solvents from drug formulations by vacuum drying
KR960021036A (ko) 콜치신을 유효성분으로 함유하는 항간독성 조성물 및 그 제조방법